Study identifier:D5970R00006
ClinicalTrials.gov identifier:NCT03031769
EudraCT identifier:N/A
CTIS identifier:N/A
Symptoms and Physical Activity in COPD patients in Europe
COPD
N/A
No
-
All
2176
Observational
40 Years - 130 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2018 by AstraZeneca
AstraZeneca
-
An observational, multinational, cross sectional study to describe 24-hs symptoms, physical activity and their relationship in stable COPD patients in Europe
The study is a multi-centre, multi country, observational prospective cross sectional study to determine the prevalence and severity of early morning, day and night-time symptoms and physical activity patterns and to evaluate their correlation between each other and with disease severity, adherence to respiratory medications, direct costs and PROs in patients with stable COPD in Europe. Approximately 2000 patients will be enrolled in convenient sites in several (9-12) selected countries.
Location
Location
Iasi, Romania
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.